LIVER DISEASES Shanghai Jiaotong University Medical School Renji Hospital Luo meng.

Slides:



Advertisements
Similar presentations
Michael Brillantes, MD, FPCS, FPSGS
Advertisements

Dr. Gehan Mohamed Dr. Abdelaty Shawky
An update on liver transplantation Joint Hospital Surgical Grand Round 19/7/2014.
SYSTEMIC HEMANGIOMATOSIS WITH ATYPICAL LIVER HEMANGIOMAS AND DIAPHRAGM INVOLVEMENT Serguey A. Khoruzhik, MD Computed Tomography, Grodno Regional Clinical.
 Treatment of malignant obstruction  Adjunct to surgery  Treatment of CBD calculi  Treatment of benign strictures  Diagnostic?  Failed ERCP.
High-Intensity Focused Ultrasound for Hepatocellular Carcinoma Joint Hospital Surgical Grand Round Queen Mary Hospital 19/10/2013.
Interventional Oncology Michael Kotton MD October 27, 2012.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 5 The Liver Part I: Abdominal Sonography Abdomen and Superficial Structures.
Hepatobiliary Anatomy and Pathology
Lung Abscess Sung Chul Hwang, M.D. Dept. of Pulmonary and Critical Care Medicine Ajou University School of Medicine.
Liver Cancer ACC RNSG Risk factors 4 th most common cancer in the world Most common primary liver cancer is hepatocellular carcinoma Cirrhosis –
Ayman Abdo MD, AmBIM, FRCPC
GALLSTONES Tanja Čujić Mentor: A. Žmegač Horvat. Anatomy of gallbladder and extrahepatic biliary tree Bile Helps the body digest fats Made in the liver.
Risk factors 4 th most common cancer in the world Cirrhosis – primary risk factor Other risk factors: hepatitis C and B Metastatic – more common than.
In the Name of GOD L iver Masses General Overview Behzad Nakhai, M.D.,FICS Fellowship in HepatoBiliary Surgery Asso Professor Iran University of Medical.
Liver Cirrhosis S. Diana Garcia
Hepatobiliary pathology By Dr/ Dina Metwaly
LIVER DISEASE Dr.Mohmmadzadeh. Anatomy Largest solid organ of body Weight : 1.5 kg From the nipple line in 4th intercostal down to the costal margin Falciform.
Liver surgery AnatomyHepatectomy Liver tumors BenignMalignant.
PORTAL HYPERTENSION & CHRONIC LIVER DISEASE SEAN CHEN ST GEORGE HEPATOBILIARY & PANCREATIC WORKSHOP 31/05/2014.
Interventional Radiology in Cancer Patients C. Douglas Edmondson, M.D., FACR C. Douglas Edmondson, M.D., FACR Interventional and Diagnostic Radiologist.
Malignant focal liver lesions
CIRRHOSISPathophysiology&Complications. What is Cirrhosis?
Liver Transplantation Philip Goodney, MD June 22, 2005.
Consultant Radiologist Prince Sultan Military Medical City
Cholestatic liver diseases:
Guzman, Alexander Joseph Hipolito, April Lorraine
肝 硬 化 Liver Cirrhosis Rukun He MD Cirrhosis is the end result of a variety of disease causing chronic liver injury. It is an irreversible.
Case Report Patient PP Submitted by:Matthew Clower, MSIV Faculty:Sandra Oldham, MD Date:29 August 2007 Radiological Category:Principal Modality (1): Principal.
Hepatocellular Carcinoma (HCC). Definition : Hepatocellular carcinoma is a primary malignancy of the hepatocyte, also known as liver cell carcinoma. Types.
Gallbladder & bile duct Carcinoma Dr. m. h.khosravi.
Mazen Hassanain. Bile duct Cancer Average age 60 years Ulcerative colitis is a common associated condition Subtypes: (1) periductal infiltrating, (2)
Introduction to Cancer
Digestive Disorders. Crohn’s Disease Chronic inflammatory bowel disease. Most common in small/large intestine. Causes: –Possible hereditary link to autoimmune.
Case Report # 1 Submitted by:James Korf, MS4 Faculty reviewer:Sandra Oldham, MD Date accepted:27 August 2014 Radiological Category:Principal Modality (1):
PANCREATIC CANCER.
OSCE Raika Jamali M.D. Gastroenterologist and hepatologist Sina hospital Tehran University of Medical Sciences.
DR/ Manal Elmahdy. Abdominal ultrasound Ultrasound is the dominant first –line of investigation for a variety of abdominal symptoms. Preparation :-
Hamid Tavakkoli, MD Associate Prof. of Gastroenterology.
肝脏疾病超声诊断 Diagnosis of Liver Disease with Ultrasound Sonography.
Faisal Al-Saif MBBS, FRCSC, ABS. - Acute Pancreatitis - Chronic Pancreatitis - Pancreatic Tumors - Pancreas Transplant.
Ischemic bile duct injury as a serious complication after TACE in patients with HCC Kim, Hae Kyung Korea Kim, Hae Kyung Korea J Clinical Gastroenterology.
HEPATIC TUMORS Dr.Cengiz Pata Gastroenterology Department Yeditepe University,Istanbul.
Affection of digestive accessory organs Liver A.Congenital abnormalities 1)Ectopia and increase number of lobes. 2)Congenital absence of the portal vein.
Liver Cancer  A leading cause of death in the world  Can be primary or a metastatic site  Seen more in other parts of the world  incidence African.
Hepatocellular carcinoma related to Hbv and Hcv
Student SYB Chet Cunha MS IV January 22, History 61 y/o M with known HCV x 5 yrs. presenting with vague abdominal discomfort. Outside CT showed.
Gall bladder and Biliary disease Dr.Umit Akyuz Gastroenterology Department Yeditepe University,Istanbul.
“Hepatocellular Carcinoma” (HCC) By Faiza Asghar.
CIRRHOSISPathophysiology&Complications. Normal liver functions Carbohydrate Metabolism Hypo- or hyperglycemia Fatty Acids Metabolism Lipid Transport.
HEPATOCELLULAR CARCINOMA (HCC) Hepatocellular Carcinoma(HCC)is macroscopically classified into four categories,which may be correlated with clinical,histologic.
Clinical History Patient presents with a palpable upper abdominal mass Patient states possible clinical history of abdominal hernia.
Department of Surgery Ruijin Clinical Medical College Shanghai Jiao Tong University.
Eun Sun Jang, M.D., Ph.D Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine Diseases.
Digestive system Diagnostic imaging department of xuzhou medical college of xuzhou medical college.
Hamid Tavakkoli, MD Associate Prof. of Gastroenterology.
Pyogenic Liver Abscess 소화기내과 R4 신아리 MGR Disease Review.
Michael J. Campbell, MD Virginia Mason Medical Center Seattle, Washington.
Differential Diagnosis
Interventional Radiology (IR) - what is that? Wojciech Ćwikiel MD
Liver Cancer.
Nodules & Tumors Nodular Hyperplasia non-cirrhotic liver nodules
Radiology of hepatobiliary diseases
Intracranial Infections in Neurosurgical Practice
Carcinoma of the Liver By: Renee Alta.
Successful TACE for HCC
Chapter 14 Hepatic Tumors, Malignant 1
Case of the Month: November 2018
Presentation transcript:

LIVER DISEASES Shanghai Jiaotong University Medical School Renji Hospital Luo meng

ANATOMYANATOMY Four channels within liver: Four channels within liver: Inflow: HA PV Inflow: HA PV Outflow: HV Biliary duct Outflow: HV Biliary duct Lobes & segments of the Liver Lobes & segments of the Liver (Couinaud’s system of segments) (Couinaud’s system of segments) Four channels within liver: Four channels within liver: Inflow: HA PV Inflow: HA PV Outflow: HV Biliary duct Outflow: HV Biliary duct Lobes & segments of the Liver Lobes & segments of the Liver (Couinaud’s system of segments) (Couinaud’s system of segments)

Three major hepatic veins drain the liver

Intrahepatic divisions of the portal vein

Liver Functions: Liver Functions: Formation of bile Formation of bile Regulation of material metabolism Regulation of material metabolism energy, carbohydrate, fat, proteins, energy, carbohydrate, fat, proteins, vitamins, hormones, and formation of vitamins, hormones, and formation of coagulant factors etc. coagulant factors etc. Mechanism of defense and detoxification Mechanism of defense and detoxification Capacity of regeneration after massive Capacity of regeneration after massive resection. resection. Liver Functions: Liver Functions: Formation of bile Formation of bile Regulation of material metabolism Regulation of material metabolism energy, carbohydrate, fat, proteins, energy, carbohydrate, fat, proteins, vitamins, hormones, and formation of vitamins, hormones, and formation of coagulant factors etc. coagulant factors etc. Mechanism of defense and detoxification Mechanism of defense and detoxification Capacity of regeneration after massive Capacity of regeneration after massive resection. resection.

LIVER ABSCESS Many kinds of LA: Pyogenic Amebic Virus & Fungi PATHOGENESIS The micro-organisms through follows to hepatic parenchyma portal venous stream ascension from biliary tract hepatic artery direct penetrating trauma Amount and ability of invasion of micro- organisms vs defense mechanism of the body. LIVER ABSCESS Many kinds of LA: Pyogenic Amebic Virus & Fungi PATHOGENESIS The micro-organisms through follows to hepatic parenchyma portal venous stream ascension from biliary tract hepatic artery direct penetrating trauma Amount and ability of invasion of micro- organisms vs defense mechanism of the body.

Etiology of pyogenic abscess

DIAGNOSIS DIAGNOSIS Clinical manifestations: Fever pain at R.U.Q. enlargement of liver Others: nausea jaundice Antecedent diarrhea in amebic liver abscess LABS: WBC↑ RBC↓ Albumin↓ blood culture for bacteria positive in 40% EXAMS: X’ray film: Elevated diaphragm and pleural effusion BUS and CT: guiding to aspiration of abscess DIAGNOSIS DIAGNOSIS Clinical manifestations: Fever pain at R.U.Q. enlargement of liver Others: nausea jaundice Antecedent diarrhea in amebic liver abscess LABS: WBC↑ RBC↓ Albumin↓ blood culture for bacteria positive in 40% EXAMS: X’ray film: Elevated diaphragm and pleural effusion BUS and CT: guiding to aspiration of abscess

CT scan of a pyogenic hepatic abscess

COMPLICATIONS Generalized sepsis, emphysema Ruptured abscess into pleural cavity, peri - cardiaum and intra-abdominal cavity TREATMENT Medical therapy: General support therapy Antibiotics, metronidazole Drainage-lavage by catheter Surgical therapy: drainage resection or of liver COMPLICATIONS Generalized sepsis, emphysema Ruptured abscess into pleural cavity, peri - cardiaum and intra-abdominal cavity TREATMENT Medical therapy: General support therapy Antibiotics, metronidazole Drainage-lavage by catheter Surgical therapy: drainage resection or of liver

PRIMARY LIVER CARCINOMA Hepatocellular carcinoma (HCC) occupied the third place of malignancy in China. Recent two decades, the higher recurrence rate has remained as a rather difficult problem in spite of the improvement in the diagnosis and treatment. PRIMARY LIVER CARCINOMA Hepatocellular carcinoma (HCC) occupied the third place of malignancy in China. Recent two decades, the higher recurrence rate has remained as a rather difficult problem in spite of the improvement in the diagnosis and treatment.

ETIOLOGY Risk factors: virus infection hepatitis type B.C.and D. various liver cirrhosis Some chemical carcinogenic material e.g. Aflatoxin PATHOLOGY macroscopic classification: massive, nodular or diffuse solitary or multiple growth pattern: infiltrative, expanded, mixed infiltrative and expanded,diffuse, small (less than 2cm in diameter) metastasis: through peri hepatic lymphatics or direct invasion particular ca thrombus in portal v. or ruptured ca into abdominal cavity ETIOLOGY Risk factors: virus infection hepatitis type B.C.and D. various liver cirrhosis Some chemical carcinogenic material e.g. Aflatoxin PATHOLOGY macroscopic classification: massive, nodular or diffuse solitary or multiple growth pattern: infiltrative, expanded, mixed infiltrative and expanded,diffuse, small (less than 2cm in diameter) metastasis: through peri hepatic lymphatics or direct invasion particular ca thrombus in portal v. or ruptured ca into abdominal cavity

Ca With Complete Capsule

CLINICAL MANIFESTATION No distinctive symptoms until late stageNo distinctive symptoms until late stage Anorexia, fullness or pain in RUQ, and weight loss are commonAnorexia, fullness or pain in RUQ, and weight loss are common In addition, clinical presentation of liver cirrhosisIn addition, clinical presentation of liver cirrhosis LAB STUDY AFP>400ng/ml in 70% of patients with HCCAFP>400ng/ml in 70% of patients with HCC Pseudo-positive (AFPV)Pseudo-positive (AFPV)

IMAGING EXAMS BUSBUS CT and MRICT and MRI Hepatic angiographyHepatic angiography Hypo-echo area IVC

CT

Hepatic angiography

An Occupied Lesion on Angiogram Hepatic angiography

HOW TO DETECT SUBCLINICAL CASES It is important that the high-risk people who are with chronic hepatitis or liver cirrhosis should be closely followed up by AFP test and BUS. It is most possible that newly identified tumors in the liver are HCC or precancerous lesion. HOW TO DETECT SUBCLINICAL CASES It is important that the high-risk people who are with chronic hepatitis or liver cirrhosis should be closely followed up by AFP test and BUS. It is most possible that newly identified tumors in the liver are HCC or precancerous lesion.

DIFFERENTIAL DIAGNOSIS Metastatic liver carcinoma Liver cirrhosis Focal nodular hyperplasia of liver Cavernous hematoangioma of liver DIFFERENTIAL DIAGNOSIS Metastatic liver carcinoma Liver cirrhosis Focal nodular hyperplasia of liver Cavernous hematoangioma of liver

TREATMENT ○ SURGICAL RESECTION Indications: Solitary, not too big multiple but collect an area Patient’s condition Evaluation of liver function (Child A or B) TREATMENT ○ SURGICAL RESECTION Indications: Solitary, not too big multiple but collect an area Patient’s condition Evaluation of liver function (Child A or B)

TREATMENT ○ SURGICAL RESECTION Surgical procedure Hemihepatectomy, lobectomy, eg mentectomy – In liver cirrhosis, limited resection with 1.5cm margin from tumor Liver transplantation –Only indicated for small HCC without outside liver spread Complication: bleeding, liver failure, sepsis TREATMENT ○ SURGICAL RESECTION Surgical procedure Hemihepatectomy, lobectomy, eg mentectomy – In liver cirrhosis, limited resection with 1.5cm margin from tumor Liver transplantation –Only indicated for small HCC without outside liver spread Complication: bleeding, liver failure, sepsis

○ Non-surgical treatment TACE under highly selective hepatic arteriocatheterization, lipoidol, cytotoxic agents and embolized material to be injected. Mainly indicated for big HCC. To make the tumor smaller in 15% patients with big HCC, the resection of tumor may be possible. INJECTION OF ETHONAL for small tumor in 2cm diameter or less OTHERS ○ Non-surgical treatment TACE under highly selective hepatic arteriocatheterization, lipoidol, cytotoxic agents and embolized material to be injected. Mainly indicated for big HCC. To make the tumor smaller in 15% patients with big HCC, the resection of tumor may be possible. INJECTION OF ETHONAL for small tumor in 2cm diameter or less OTHERS

Angiography---Chemo- embolization The Lesion Getting Smaller 2 Months Later

Ca Showed by Hypo-echo After Chemo-embolization

Chemo-embolization

Multiple Liver Cysts (Congenital)

李 × 男性 62 岁, 17 月前因肝癌行肝癌 根治术, 术后随访中发现 α -FP 呈进行 性上升, B 超及 CT 均未发现明显病变, 动脉造影证实肝内肝癌复发

Occupied Lesion on Angiogram

Recurrent liver cancer